Literature DB >> 27174556

A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.

Gregory P Strauss1, James M Gold2.   

Abstract

In 2005, the National Institute of Mental Health held a consensus development conference on negative symptoms of schizophrenia. Among the important conclusions of this meeting were that there are at least 5 commonly accepted domains of negative symptoms (blunted affect, alogia, avolition, anhedonia, asociality) and that new rating scales were needed to adequately assess these constructs. Two next-generation negative symptom scales resulted from this meeting: the Brief Negative Symptom Scale (BNSS) and Clinical Assessment Interview for Negative Symptoms (CAINS). Both measures are becoming widely used and studies have demonstrated good psychometric properties for each scale. The current study provides the first direct psychometric comparison of these scales. Participants included 65 outpatients diagnosed with schizophrenia or schizoaffective disorder who completed clinical interviews, questionnaires, and neuropsychological testing. Separate raters completed the BNSS and CAINS within the same week. Results indicated that both measures had good internal consistency, convergent validity, and discriminant validity. High correspondence was observed between CAINS and BNSS blunted affect and alogia items. Moderate convergence occurred for avolition and asociality items, and low convergence was seen among anhedonia items. Findings suggest that both scales have good psychometric properties, but that there are important distinctions among the items related to motivation and pleasure.
© The Author 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  assessment; negative symptoms; psychosis

Mesh:

Year:  2016        PMID: 27174556      PMCID: PMC5049528          DOI: 10.1093/schbul/sbw046

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  42 in total

Review 1.  A new perspective on anhedonia in schizophrenia.

Authors:  Gregory P Strauss; James M Gold
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

2.  Unseen Affective Faces Influence Person Perception Judgments in Schizophrenia.

Authors:  Ann M Kring; Erika H Siegel; Lisa Feldman Barrett
Journal:  Clin Psychol Sci       Date:  2014-07

3.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

4.  Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.

Authors:  Gregory P Strauss; William R Keller; James I Koenig; James M Gold; Kathryn L Ossenfort; Robert W Buchanan
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

5.  Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia.

Authors:  Gregory P Strauss; William R Keller; James I Koenig; Sara K Sullivan; James M Gold; Robert W Buchanan
Journal:  Schizophr Res       Date:  2015-01-22       Impact factor: 4.939

6.  Speech deficits in serious mental illness: a cognitive resource issue?

Authors:  Alex S Cohen; Jessica E McGovern; Thomas J Dinzeo; Michael A Covington
Journal:  Schizophr Res       Date:  2014-11-17       Impact factor: 4.939

Review 7.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

8.  Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia.

Authors:  Katiah Llerena; Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Res       Date:  2012-10-03       Impact factor: 4.939

9.  Computerized measurement of negative symptoms in schizophrenia.

Authors:  Alex S Cohen; Murray Alpert; Tasha M Nienow; Thomas J Dinzeo; Nancy M Docherty
Journal:  J Psychiatr Res       Date:  2007-10-24       Impact factor: 4.791

10.  Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

Authors:  James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank
Journal:  Biol Psychiatry       Date:  2013-02-07       Impact factor: 13.382

View more
  20 in total

Review 1.  A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Authors:  Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Res       Date:  2020-06-07       Impact factor: 4.939

2.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

Review 3.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

Review 4.  Negative Symptoms and Cognitive Impairments in Schizophrenia: Two Key Symptoms Negatively Influencing Social Functioning.

Authors:  Koichi Kaneko
Journal:  Yonago Acta Med       Date:  2018-06-18       Impact factor: 1.641

5.  Effortful goal-directed behavior in schizophrenia: Computational subtypes and associations with cognition.

Authors:  Jessica A Cooper; Deanna M Barch; L Felice Reddy; William P Horan; Michael F Green; Michael T Treadway
Journal:  J Abnorm Psychol       Date:  2019-07-08

6.  Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.

Authors:  David C Cicero; Katherine G Jonas; Kaiqiao Li; Greg Perlman; Roman Kotov
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

7.  Early-Stage Negative Symptom Trajectories and Relationships With 13-Year Outcomes in First-Episode Nonaffective Psychosis.

Authors:  Wing Chung Chang; Ryan Wui Hang Ho; Jennifer Yee Man Tang; Corine Sau Man Wong; Christy Lai Ming Hui; Sherry K W Chan; Edwin M H Lee; Yi Nam Suen; Eric Y H Chen
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

8.  A Meta-Analysis of Neuropsychological Effort Test Performance in Psychotic Disorders.

Authors:  Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Gregory P Strauss
Journal:  Neuropsychol Rev       Date:  2020-08-07       Impact factor: 7.444

9.  Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum.

Authors:  Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

10.  The Latent Structure of Negative Symptoms in Schizophrenia.

Authors:  Gregory P Strauss; Alicia Nuñez; Anthony O Ahmed; Kimberly A Barchard; Eric Granholm; Brian Kirkpatrick; James M Gold; Daniel N Allen
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.